These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 10701146)

  • 1. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease.
    Mahida YR
    Inflamm Bowel Dis; 2000 Feb; 6(1):21-33. PubMed ID: 10701146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of the mucosal immune system in inflammatory bowel disease.
    MacDermott RP
    J Gastroenterol; 1996 Dec; 31(6):907-16. PubMed ID: 9027661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current concept of the role of monocytes/macrophages in inflammatory bowel disease--balance of proinflammatory and immunosuppressive mediators.
    Lügering N; Kucharzik T; Stoll R; Domschke W
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):338-44. PubMed ID: 9759608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The cytokines in inflammatory bowel disease].
    Polińska B; Matowicka-Karna J; Kemona H
    Postepy Hig Med Dosw (Online); 2009 Aug; 63():389-94. PubMed ID: 19724079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New mediators of immunity and inflammation in inflammatory bowel disease.
    Monteleone G; Fina D; Caruso R; Pallone F
    Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of interleukin 17 in inflammatory bowel disease.
    Fujino S; Andoh A; Bamba S; Ogawa A; Hata K; Araki Y; Bamba T; Fujiyama Y
    Gut; 2003 Jan; 52(1):65-70. PubMed ID: 12477762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunopathogenesis of inflammatory bowel diseases].
    Neurath MF; Schürmann G
    Chirurg; 2000 Jan; 71(1):30-40. PubMed ID: 10662999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokines in the inflammatory bowel diseases.
    MacDermott RP
    J Clin Immunol; 1999 Sep; 19(5):266-72. PubMed ID: 10535602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytokines in the pathogenesis of inflammatory bowel diseases].
    José León A; Garrote JA; Arranz E
    Med Clin (Barc); 2006 Jun; 127(4):145-52. PubMed ID: 16831396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proportion of CD40+ mucosal macrophages is increased in inflammatory bowel disease whereas CD40 ligand (CD154)+ T cells are relatively decreased, suggesting differential modulation of these costimulatory molecules in human gut lamina propria.
    Carlsen HS; Yamanaka T; Scott H; Rugtveit J; Brandtzaeg P
    Inflamm Bowel Dis; 2006 Nov; 12(11):1013-24. PubMed ID: 17075342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune mechanisms in chronic inflammatory bowel disease.
    Braegger CP; MacDonald TT
    Ann Allergy; 1994 Feb; 72(2):135-41. PubMed ID: 8109803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.
    Globig AM; Hennecke N; Martin B; Seidl M; Ruf G; Hasselblatt P; Thimme R; Bengsch B
    Inflamm Bowel Dis; 2014 Dec; 20(12):2321-9. PubMed ID: 25248005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological disorders in inflammatory bowel disease and immunotherapeutic implications.
    Amati L; Caradonna L; Jirillo E; Caccavo D
    Ital J Gastroenterol Hepatol; 1999 May; 31(4):313-25. PubMed ID: 10425578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14+L1+ monocyte derived cells.
    Rugtveit J; Haraldsen G; Høgåsen AK; Bakka A; Brandtzaeg P; Scott H
    Gut; 1995 Sep; 37(3):367-73. PubMed ID: 7590432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease.
    McAlindon ME; Hawkey CJ; Mahida YR
    Gut; 1998 Feb; 42(2):214-9. PubMed ID: 9536946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
    Nakase H; Okazaki K; Tabata Y; Chiba T
    J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine expression in gingival and intestinal tissues of patients with periodontitis and inflammatory bowel disease: An exploratory study.
    Menegat JS; Lira-Junior R; Siqueira MA; Brito F; Carvalho AT; Fischer RG; Figueredo CM
    Arch Oral Biol; 2016 Jun; 66():141-6. PubMed ID: 26946440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines in inflammatory bowel disease.
    Rogler G; Andus T
    World J Surg; 1998 Apr; 22(4):382-9. PubMed ID: 9523521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease.
    Reimund JM; Dumont S; Muller CD; Kenney JS; Kedinger M; Baumann R; Poindron P; Duclos B
    Gut; 1997 Apr; 40(4):475-80. PubMed ID: 9176074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.